Artiva Biotherapeutics, Inc. Common Stock (ARTV) — Financial Flexibility Index
Artiva Biotherapeutics, Inc. Common Stock (ARTV) has a Financial Flexibility Index of -0.95x as of September 2025. Free cash flow of $-18.60 Million (operating CF $-19.20 Million minus capex $600.00K) represents -1% of total liabilities ($19.64 Million). Check Artiva Biotherapeutics, Inc. Common Stoc PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Artiva Biotherapeutics, Inc. Common Stock Financial Flexibility Index (2020–2024)
Historical Financial Flexibility Index trend for Artiva Biotherapeutics, Inc. Common Stock across 5 annual periods. See Artiva Biotherapeutics, Inc. Common Stoc short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Artiva Biotherapeutics, Inc. Common Stock (2020–2024)
Year-by-year free cash flow to debt coverage for Artiva Biotherapeutics, Inc. Common Stock. For the full company profile including market capitalisation, see Artiva Biotherapeutics, Inc. Common Stoc market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -2.37x | $-54.39 Million | $-55.03 Million | $22.94 Million | ▼ -1333.8% |
| 2023 | -0.17x | $-44.17 Million | $-47.43 Million | $267.13 Million | ▼ -1.7% |
| 2022 | -0.16x | $-44.53 Million | $-50.83 Million | $273.75 Million | ▼ -210.0% |
| 2021 | -0.05x | $-13.58 Million | $-15.30 Million | $258.78 Million | ▲ +79.9% |
| 2020 | -0.26x | $-13.26 Million | $-13.54 Million | $50.80 Million | — |